Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Current Leases (2021 - 2022)

Cellectis (CLLS) posted quarterly Current Leases of $6.3 million for Q1 2026, down 20.44% year-over-year from $7.9 million in Q1 2025, and down 18.78% quarter-over-quarter from $7.7 million in Q4 2025.

Analysis

Cellectis (CLLS) Current Leases (2021 - 2022) Analysis & Trends

Cellectis' Current Leases history runs 11 years deep, the most recent figure standing at $6.3 million for Q1 2026.

  • In Q1 2026, Current Leases fell 20.44% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 20.44% YoY), while the FY2025 annual figure was $7.7 million, down 8.16% from the prior year.
  • Current Leases for Q1 2026 stood at $6.3 million, down from $7.7 million in the prior quarter.
  • The five-year high for Current Leases was $8.5 million in Q3 2024, with the low at $6.3 million in Q1 2026.
  • The 5-year median for Current Leases is $8.2 million (2023), against an average of $8.0 million.
  • The sharpest annual moves came in 2022 and 2026: Current Leases advanced 20.37% in 2022, then dropped 20.44% in 2026.
  • Cellectis' Current Leases stood at $7.9 million in 2022, then grew by 8.0% to $8.5 million in 2023, then dropped by 1.38% to $8.4 million in 2024, then slipped by 8.16% to $7.7 million in 2025, then fell by 18.78% to $6.3 million in 2026.
  • Business Quant data shows CLLS's Current Leases at $6.3 million in Q1 2026, $7.7 million in Q4 2025, and $8.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 97,000.00
Mar 31, 2022 290,000.00
Dec 31, 2021 370,000.00